期刊文献+

组织工程心脏瓣膜不同脱细胞方法的比较 被引量:1

Comparison of various acellular methods for tissue-engineered heart valves
下载PDF
导出
摘要 背景:目前对几种脱细胞方法的效果各家观点不同。大都认为各种方法均可去除细胞,但实验结果却有较大差异。目的:对比胰蛋白酶法、十二烷基硫酸钠法和去氧胆酸钠法去除细胞后心脏瓣膜形态学及生物力学特征。设计、时间及地点:对比观察实验,于2007-10/2008-07在上海交通大学医学院细胞生物学实验室和上海交通大学医学院附属新华医院进行。材料:40个新鲜猪主动脉瓣120片瓣叶分为3组,分别为胰蛋白酶组、十二烷基硫酸钠组和去氧胆酸钠组,每组40片。方法:胰蛋白酶消化法:置于0.5g/L胰蛋白酶和0.2g/L乙二胺四乙酸,在37℃,体积分数为0.05CO2培养箱中振荡24h。十二烷基硫酸钠法:置于0.3g/L十二烷基硫酸钠和DNase,RNase中持续振荡24h。去氧胆酸钠法:首先在5g/LTriton-X100,5g/L去氧胆酸钠,0.2g/L乙二胺四乙酸中振荡24h,然后在2.5g/LTriton-X100,2.5g/L去氧胆酸钠和0.2g/L乙二胺四乙酸中破膜去污振荡48h,两阶段均加入DNase,RNase。主要观察指标:3种方法去细胞前后心脏瓣膜的生物力学特性变化。3种方法去除细胞程度和对胶原纤维、弹力纤维的影响。结果:去氧胆酸钠组拉伸率、最大拉伸应力、最大载荷均高于十二烷基硫酸钠组和胰蛋白酶组(P<0.01)。胰蛋白酶法脱细胞效果差,对基质破坏明显;十二烷基硫酸钠法可完全脱细胞,对基质破坏较大;去氧胆酸钠法完全脱细胞同时对基质破坏较少。结论:与胰蛋白酶法、十二烷基硫酸钠法比较,去氧胆酸钠法脱细胞效果好,能更好保护基质。 BACKGROUND: Presently, the acellular methods are various, but the experimental results are different. OBJECTIVE: To compare the differences of heart valve morphology and biomechanics after treated with either trypsin or sodium-dodecyl-sulfate (SDS) or Triton-X 100 and sodium-deoxycholate. DESIGN, TIME AND SETTING: A controlled experiment was performed at the Cytobiology Laboratory and Xinhua Hospital Affiliated to Medical College of Shanghai Jiaotong University from October 2007 to July 2008. MATERIALS: 120 fresh aortic valve leaflets of 40 pigs were equally divided into a trypsin group, SDS group and sodium-deoxycholate group. METHODS: Samples of the trypsin group were treated with 0.5 g/L trypsin and 0.2 g/L ethylenediamine tetraacetic acid (EDTA) under permanent shaking for 24 hours at 37 ℃ in a 0.02 volume fraction CO2 incubator. Samples in the SDS group were placed in SDS concentrations of 0.3 g/L with added RNase and DNase under permanent shaking for 24 hours. The left tissues were treated with 5 g/L sodium deoxycholate, 5 g/L Triton-X 100 and 0.2 g/L EDTA for 24 hours of shaking, and 2.5 g/L sodium deoxycholate, 2.5 g/L Triton-X 100 and 0.2 g/L EDTA separately for 48 hours of shaking, in addition to RNase and DNase. MAIN OUTCOME MEASURES: Valvular biomechanics characteristic changes of the before and after acellular treatment using three various methods. The acellular degree, and effects of the three methods on collagen fibers, elastic fibers. RESULTS: Extension rate, maximal tensile stress and maximal load were higher in the sodium-deoxycholate group than in the SDS group and sodium-deoxycholate group (P 〈 0.01). The acellular outcome was poor using the trypsin method, and a significant destruction on the matrix could be found. The SDS method had good acellular outcomes, but also had a great destruction on the matrix. The sodium-deoxycholate method had good acellular outcomes, and also had little destruction on the matrix. CONCLUSION: Compared with trypsin and SDS methods, the sodium-deoxycholate method obtains an optimal acellular outcome and can protect the matrix.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第49期9619-9622,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献17

  • 1Van Lieshout M, Peters G, Rutten M,et al. A knitted, fibrin-covered polycaprolactone scaffold for tissue engineering of the aortic valve. Tissue Eng 2006:12(3):481-487
  • 2Mol A, Rutten MC, Driessen NJ,et al. Autologous human tissue-engineered heart valves: prospects for systemic application. Circulation 2006;114(1 Suppl):I152-I158
  • 3Mei N, Chen G. Zhou Ret al. Biocompatibility of Poly(epsilon-caprolactone) scaffold modified by chitosan-the fibroblasts oroliferation in vitro. J B i omater Appl 2005; 19(4) :323 -339
  • 4Masters KS, Shah DN, Leinwand LA, et al.Crosslinked hyaluronan scaffolds as a biologically active carder for valvular interstitial cells. Biomaterials 2005;26(15):2517-2525
  • 5Kasimir MT, Rieder E, Seebacher G, et al. Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs 2003;26(5):421-427
  • 6Mirsadraee S, Wilcox HE, Korossis SA,et al. Development and characterization of an acellular human pericardial matrix for tissue engineering. Tissue Eng 2006;12(4):763-773
  • 7杨岷,陈长志,成少飞,王学宁,叶清,王维俊,王小妹.牛心包组织工程心脏瓣膜支架脱细胞方法的比较[J].中华胸心血管外科杂志,2005,21(6):349-351. 被引量:16
  • 8王克学,张镜方,詹秋鹏,简旭华.胰蛋白酶法和Triton-X100法去除瓣膜细胞的效果比较[J].第一军医大学学报,2005,25(1):22-25. 被引量:11
  • 9Steinhoff G, Stock U, Karim N,et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation 2000; 102(19 Suppl 3):Ⅲ50-Ⅲ55
  • 10Oei FB, Stegmann AP, van der Ham F, et al. The presence of immune stimulatory cells in fresh and cryopreserved donor aortic and pulmonary valve allografts. J Heart Valve Dis 2002;11(3):315-324

二级参考文献26

  • 1Oei FB, Stegmann AP, van der Ham F, et al. The presence of immune stimulatory cells in fresh and cryopreserved donor aortic and pulmonary valve allografts. J Heart Valve Dis, 2002,11:315-324.
  • 2Simon P, Kasimir MT, Seebacher G, et al. Early failure of the tissue engineered porcine heart valve synergraft in pediatric patients. Eur J Cardiothorac Surg, 2003,23:1002-1006.
  • 3Badylak SF. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol, 2004,12:367-377.
  • 4Kim WG, Park JK, Lee WY. Tissue-engineered heart valve leaflets: an effective method of obtaining acellularized valve xenografts. Int J Artif Organs, 2002,25:791-797.
  • 5Courtman DW, Pereira CA, Kashef V, et al. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mate Res,1994,28:655-666.
  • 6Steinhoff G, Stock U, Karim N, et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation, 2000,102(19 Suppl 3):III50-55.
  • 7Schenke-Layland K, Opitz F, Gross M, et al. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study. Cardiovasc Res,2003,60:497-509.
  • 8Kasimir MT, Rieder E, Seebacher G, et al. Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs,2003,26:421-427.
  • 9Stock UA, Vacanti JP, Mayer-Jr JE, et al. Tissue engineering of heart valves-current aspects [J]. Thorac Cardiovasc Surg, 2002, 50(3): 184-93.
  • 10Nugent HM, Edelman ER. Tissue engineering therapy for cardiovascular disease[J]. Circ Res, 2003, 92(10): 1068-78.

共引文献23

同被引文献18

  • 1王克学,张镜方,詹秋鹏,简旭华.胰蛋白酶法和Triton-X100法去除瓣膜细胞的效果比较[J].第一军医大学学报,2005,25(1):22-25. 被引量:11
  • 2Sievers I-IH, Stierle U, Schmidtke C, et al. Decellularized pulmonary homograft (SynerGraft) for Reconstruction of the right ventricular outflow tract: first clinical experience[J]. Z Kardiol, 2003, 92(1): 53-9.
  • 3Dohmen PM, Lembcke A, Holinski S, et al. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure [J]. Ann Thorac Surg, 2007, 84(3): 729-36.
  • 4Hiemarm NE, Mani M, Huebler M, et al. Complete destruction of a tissue-engineered porcine xenograft in pulmonary valve position after the Ross procedure[J]. J Thorac Cardiovasc Surg, 2010, 139 (4): e67-8.
  • 5Ruffer A, Purbojo A, Cicha I, et al. Early failure of xenogenous de-cellularised pulmonary valve conduits--a Word of caution [J]. Eur J Cardiothorac Surg, 2010, 38(1): 78-85.
  • 6Simon P, Kasimir MT, Seebacher G, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients [J]. Eur J Cardiothorac Surg, 2003, 23(6): 1002-6.
  • 7O'brien M, Goldstein S, Walsh S, et al. The Synergraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve implantation [Jl. Semin Thorac Cardiovasc Surg, 1999, 11(4 suppl 1): 194-200.
  • 8Sharp MA, Phillips D, Roberts I, et al. A cautionary case: the SynerGraft vascular prosthesis[J]. Eur J Vasc Endovasc Surg, 2004, 27(1): 42-4.
  • 9Naso F, Gandaglia A, Iop L, et al. First quantitative assay of alpha- Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves IJ]. Acta Biomater, 2011, 7(4): 1728-34.
  • 10Rieder E, Seebacher G, Kasimir MT, et al. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells[J]. Circulation, 2005, 111(21): 2792-7.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部